34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 1 : National Harbor, MD, USA. 6-10 November 2019.

J Immunother Cancer · 2019 · PMC6833189 · PMID 31694725

Europe PMC DOI

hedged sentences

0.2100

closest p · 4.2× alpha

0.2100

boldest claim

The sentences

showed a trendp=0.21not close (p > 0.1)

M-H patients showed a trend towards lower median overall survival in SqCC and ADC (75 vs 63 months p=0.21; 53 vs 50 months, p=0.14, Figure 3C,3D).

also in 53,322 other papers

a clear trendno p-value reported

did not reach statistical significanceno p-value reported

In patients treated with PD-1 axis blockers, elevated baseline γH2Ax/CD3 was associated with a clear trend toward longer survival but did not reach statistical significance.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.